Digitisation | November 02, 2021
SOPHiA Genetics launches SOPHiA DDM to assist Agilent customers
New bioinformatic workflow advances analysis capabilities for whole-exome assessment and interpretation
New bioinformatic workflow advances analysis capabilities for whole-exome assessment and interpretation
The company is a medical dictation solution used by medical practitioners
Its unique technology, ChetoSensar gives new promise to ADCs by alleviating solubility challenges
The acquisition expands Takeda’s immuno-oncology and innate immune cell therapy portfolio with novel platforms leveraging T cells for the potential treatment of solid tumours and haematological malignancies
Gini Health works in the domain of personalised healthcare
It is the first integrated digital PCR solution ideal for oncology, cell and gene therapy development
Dr Lal PathLabs revenue contribution from west India to go up from 10% to 24% post-acquisition basis FY21
It has exercised intellectual property options from IP Group regarding research results generated by the UK Cystic Fibrosis Gene Therapy Consortium, and from Oxford Biomedica regarding their lentiviral vector technology
Everlife leads the series A round, and SPRIM Global Investments participates in the financing syndicate
Harvard Medical School will deliver the first customized program, ‘Accelerate’, to create the next generation of leading experts in clinical development and medical affairs
Subscribe To Our Newsletter & Stay Updated
